Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma

Head and Neck

Volumn 33, Issue 6, 2011, Pages 856-862

  Weiss, Daniel ^a   Koopmann, Mario ^a   Rudack, Claudia ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

carcinoma of unknown primary; cervical lymph node metastasis; cyclin dependent kinase inhibitor p16; head and neck squamous cell carcinoma; human papillomavirus 16

Indexed keywords

CISPLATIN; FLUOROURACIL; PROTEIN P16; VIRUS DNA;

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER SURVIVAL; CERVICAL LYMPH NODE; CHEMORADIOTHERAPY; DNA EXTRACTION; FEMALE; GENE OVEREXPRESSION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OROPHARYNX TUMOR; PREVALENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONSILLECTOMY; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; COHORT STUDIES; DNA, VIRAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 16; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NECK; NEOPLASMS, SQUAMOUS CELL; PAPILLOMAVIRUS INFECTIONS; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED;

EID: 79955879681     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21548     Document Type: Article

References (21)

1. Parkin DM, Bray F, Ferlay J, Pisani P,. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001; 94: 153-156. (Pubitemid 32911406)
2. D'souza G, Kreimer AR, Viscidi R, et al. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 2007; 356: 1944-1956. (Pubitemid 46740304)
3. Termine N, Panzarella V, Falaschini S, et al. HPV in oral squamous cell carcinoma vs head and neck squamous cell carcinoma biopsies: a meta-analysis (1988-2007). Ann Oncol 2008; 19: 1681-1690.
4. Jung AC, Briolat J, Millon R, et al. Biological and clinical relevance of transcriptionally active human papillomavirus (HPV) infection in oropharynx squamous cell carcinoma. Int J Cancer 2010; 126: 1882-1894.
5. zur Hausen H,. Papillomavirus causing cancer: evasion from host-cell control in early events in carcinogenesis. J Natl Cancer Inst 2000; 92: 690-698. (Pubitemid 30365529)
6. Psyrri A, Prezas L, Burtness B,. Oropharyngeal cancer. Clin Adv Hematol Oncol 2008; 6: 604-612.
7. Kuo KT, Hsiao CH, Lin CH, Kuo LT, Huang SH, Lin MC,. The biomarkers of human papillomavirus infection in tonsillar squamous cell carcinoma-molecular basis and predicting favorable outcome. Mod Pathol 2008; 21: 376-386.
8. Weinberger PM, Yu Z, Haffty BG, et al. Molecular classification identifies a subset of human papillomavirus - associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 2006; 24: 736-747. (Pubitemid 46622040)
9. Ferris RL, Martinez I, Sirianni N, et al. Human papillomavirus-16 associated squamous cell carcinoma of the head and neck (SCCHN): a natural disease model provides insights into viral carcinogenesis. Eur J Cancer 2005; 41: 807-815. (Pubitemid 40342563)
10. McNeil C,. HPV in oropharyngeal cancers: new data inspire hope for vaccines. J Natl Cancer Inst 2000; 92: 680-681.
11. Goldenberg D, Begum S, Westra WH, et al. Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 2008; 30: 898-903. (Pubitemid 352008950)
12. Cardesa AN, Gale N, Nadal A, Zidar N,. Tumors of the oral cavity and oropharynx. In:, Barnes L, Eveson JW, Reichart P, Sidransky D, editors. World Health Organization Classification of Tumours, Pathology and Genetics of Head and Neck Tumors. Lyon (France): IARC Press; 2005. pp 118-181.
13. Chan PK, Chan DP, To KF, Yu MY, Cheung JL, Cheng AF,. Evaluation of extraction methods from paraffin wax embedded tissues for PCR amplification of human and viral DNA. J Clin Pathol 2001; 54: 401-403. (Pubitemid 32458142)
14. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL,. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002; 94: 2199-2210. (Pubitemid 34411978)
15. Tidow N, Boecker A, Schmidt H, et al. Distinct amplification of an untranslated regulatory sequence in the EGFR gene contributes to early steps in breast cancer development. Cancer Res 2003; 63: 1172-1178. (Pubitemid 36348690)
16. Klussmann JP, Weissenborn SJ, Wieland U, et al. Prevalence, distribution, and viral load of human papillomavirus 16 DNA in tonsillar carcinomas. Cancer 2001; 92: 2875-2884.
17. Begum S, Cao D, Gillison M, Zahurak M, Westra WH,. Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 2005; 11: 5694-5699. (Pubitemid 41170292)
18. Reed AL, Califano J, Cairns P, et al. High frequency of p16 (CDKN2A/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. Cancer Res 1996; 56: 3630-3633. (Pubitemid 26272001)
19. Smeets SJ, Hesselink AT, Speel EJ, et al. A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 2007; 121: 2465-2472. (Pubitemid 350022416)
20. Devaney KO, Rinaldo A, Ferlito A, et al. Squamous carcinoma arising in a branchial cleft cyst: have you ever treated one? Will you? J Laryngol Otol 2008; 122: 547-550. (Pubitemid 351769813)
21. Ragin CC, Taioli E,. Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis. Int J Cancer 2007; 121: 1813-1820. (Pubitemid 47417302)